Abstract
Background: Matrix metalloproteinases (MMPs) have been implicated in development of atherosclerosis. MMPs are activated in patients with acute coronary syndrome (ACS). However, little data exist regarding the correlation between circulating levels of MMPs and plaque volume (PV) in patients with ACS. We therefore evaluated the impact of MMPs on coronary PV as a post hoc analysis from the JAPAN-ACS study. Methods: The multicenter JAPAN-ACS trial revealed that aggressive statin therapy for patients with ACS significantly reduces coronary PV determined by intravascular ultrasound (IVUS). We studied 248 ACS patients who had serial IVUS examinations over 8-12 months in the trial. For each patient, MMP-1, 2, and 3 were measured both at baseline and at study end to evaluate the correlation between the percent change of PV and MMP levels. Results: MMP-3 levels were significantly decreased during the follow-up period (100 ng/mL to 73 ng/mL, p < 0.001), in contrast, MMP-1, -2 levels were significantly increased. MMP-3 levels at follow-up correlated with coronary plaque regression (p for trend = 0.016). A multivariable linear regression model showed both MMP-2 and MMP-3 levels at follow-up were independent variables for change of coronary PV (p = 0.038 and p = 0.016, respectively). Conclusion: Circulating MMPs levels are associated with changes in coronary plaque volume determined by serial IVUS in patients with ACS.
| Original language | English |
|---|---|
| Pages (from-to) | 275-280 |
| Number of pages | 6 |
| Journal | Atherosclerosis |
| Volume | 226 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 01-01-2013 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Cardiology and Cardiovascular Medicine
Cite this
}
Association between circulating matrix metalloproteinase levels and coronary plaque regression after acute coronary syndrome - Subanalysis of the JAPAN-ACS study. / Ogita, Manabu; Miyauchi, Katsumi; Morimoto, Takeshi; Daida, Hiroyuki; Kimura, Takeshi; Hiro, Takafumi; Nakagawa, Yoshihisa; Yamagishi, Masakazu; Ozaki, Yukio; Matsuzaki, Masunori.
In: Atherosclerosis, Vol. 226, No. 1, 01.01.2013, p. 275-280.Research output: Contribution to journal › Article
TY - JOUR
T1 - Association between circulating matrix metalloproteinase levels and coronary plaque regression after acute coronary syndrome - Subanalysis of the JAPAN-ACS study
AU - Ogita, Manabu
AU - Miyauchi, Katsumi
AU - Morimoto, Takeshi
AU - Daida, Hiroyuki
AU - Kimura, Takeshi
AU - Hiro, Takafumi
AU - Nakagawa, Yoshihisa
AU - Yamagishi, Masakazu
AU - Ozaki, Yukio
AU - Matsuzaki, Masunori
PY - 2013/1/1
Y1 - 2013/1/1
N2 - Background: Matrix metalloproteinases (MMPs) have been implicated in development of atherosclerosis. MMPs are activated in patients with acute coronary syndrome (ACS). However, little data exist regarding the correlation between circulating levels of MMPs and plaque volume (PV) in patients with ACS. We therefore evaluated the impact of MMPs on coronary PV as a post hoc analysis from the JAPAN-ACS study. Methods: The multicenter JAPAN-ACS trial revealed that aggressive statin therapy for patients with ACS significantly reduces coronary PV determined by intravascular ultrasound (IVUS). We studied 248 ACS patients who had serial IVUS examinations over 8-12 months in the trial. For each patient, MMP-1, 2, and 3 were measured both at baseline and at study end to evaluate the correlation between the percent change of PV and MMP levels. Results: MMP-3 levels were significantly decreased during the follow-up period (100 ng/mL to 73 ng/mL, p < 0.001), in contrast, MMP-1, -2 levels were significantly increased. MMP-3 levels at follow-up correlated with coronary plaque regression (p for trend = 0.016). A multivariable linear regression model showed both MMP-2 and MMP-3 levels at follow-up were independent variables for change of coronary PV (p = 0.038 and p = 0.016, respectively). Conclusion: Circulating MMPs levels are associated with changes in coronary plaque volume determined by serial IVUS in patients with ACS.
AB - Background: Matrix metalloproteinases (MMPs) have been implicated in development of atherosclerosis. MMPs are activated in patients with acute coronary syndrome (ACS). However, little data exist regarding the correlation between circulating levels of MMPs and plaque volume (PV) in patients with ACS. We therefore evaluated the impact of MMPs on coronary PV as a post hoc analysis from the JAPAN-ACS study. Methods: The multicenter JAPAN-ACS trial revealed that aggressive statin therapy for patients with ACS significantly reduces coronary PV determined by intravascular ultrasound (IVUS). We studied 248 ACS patients who had serial IVUS examinations over 8-12 months in the trial. For each patient, MMP-1, 2, and 3 were measured both at baseline and at study end to evaluate the correlation between the percent change of PV and MMP levels. Results: MMP-3 levels were significantly decreased during the follow-up period (100 ng/mL to 73 ng/mL, p < 0.001), in contrast, MMP-1, -2 levels were significantly increased. MMP-3 levels at follow-up correlated with coronary plaque regression (p for trend = 0.016). A multivariable linear regression model showed both MMP-2 and MMP-3 levels at follow-up were independent variables for change of coronary PV (p = 0.038 and p = 0.016, respectively). Conclusion: Circulating MMPs levels are associated with changes in coronary plaque volume determined by serial IVUS in patients with ACS.
UR - http://www.scopus.com/inward/record.url?scp=84871372560&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84871372560&partnerID=8YFLogxK
U2 - 10.1016/j.atherosclerosis.2012.10.063
DO - 10.1016/j.atherosclerosis.2012.10.063
M3 - Article
VL - 226
SP - 275
EP - 280
JO - Atherosclerosis
JF - Atherosclerosis
SN - 0021-9150
IS - 1
ER -